Both conjugates are significantly more cytotoxic than the non-conjugated complexes and the free antibody, with EC50 values in the sub-micromolar range against the HER2(+) MCF-7 and BT-474 breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.